| dbo:abstract |
ماباتوموماب هو جسم مضاد وحيد النسيلة بشري تجريبي يخوض تجاربه السريرية لعلاج السرطان. (ar) Mapatumumab (HGS-ETR1) is an experimental human monoclonal antibody undergoing clinical trials for the treatment of cancer. It targets TRAIL-R1, also known as DR4, which is expressed on the surface of many tumor cell types. (en) |
| dbo:casNumber |
658052-09-6 |
| dbo:fdaUniiCode |
WZ1025JPGR |
| dbo:wikiPageID |
9700653 (xsd:integer) |
| dbo:wikiPageLength |
9261 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1102283529 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Cambridge_Antibody_Technology dbr:Carboplatin dbr:Monotherapy dbr:Non-Hodgkin’s_lymphoma dbr:Bortezomib dbr:Human dbr:Human_Genome_Sciences dbc:GSK_plc_brands dbr:Colorectal_cancer dbr:GlaxoSmithKline dbr:Monoclonal_antibody dbr:Multiple_myeloma dbr:TRAIL-R1 dbc:Experimental_cancer_drugs dbr:Lexatumumab dbr:Liver_cancer dbr:Clinical_trial dbr:Paclitaxel dbr:Phage_display dbr:AstraZeneca dbc:Monoclonal_antibodies_for_tumors dbr:TRAIL dbr:Sorafenib dbr:Non-small-cell_lung_cancer dbr:Solid_tumor dbr:Death_receptor |
| dbp:atcPrefix |
none (en) |
| dbp:c |
6748 (xsd:integer) |
| dbp:casNumber |
658052 (xsd:integer) |
| dbp:chemspiderid |
none (en) |
| dbp:h |
10408 (xsd:integer) |
| dbp:mabType |
mab (en) |
| dbp:n |
1800 (xsd:integer) |
| dbp:o |
2092 (xsd:integer) |
| dbp:s |
52 (xsd:integer) |
| dbp:source |
u (en) |
| dbp:target |
TRAIL-receptor (en) |
| dbp:type |
mab (en) |
| dbp:unii |
WZ1025JPGR (en) |
| dbp:verifiedfields |
changed (en) |
| dbp:verifiedrevid |
462100121 (xsd:integer) |
| dbp:watchedfields |
changed (en) |
| dbp:wikiPageUsesTemplate |
dbt:Drugbox dbt:Reflist dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Fdacite dbt:Monoclonals_for_tumors |
| dcterms:subject |
dbc:GSK_plc_brands dbc:Experimental_cancer_drugs dbc:Monoclonal_antibodies_for_tumors |
| gold:hypernym |
dbr:Antibody |
| rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:MonoclonalAntibody yago:WikicatMonoclonalAntibodiesForTumors yago:Abstraction100002137 yago:Antibody115027189 yago:Chemical114806838 yago:Compound114818238 yago:Macromolecule114944888 yago:Material114580897 yago:Matter100020827 yago:Molecule114682133 yago:MonoclonalAntibody115029781 yago:OrganicCompound114727670 yago:Part113809207 yago:PhysicalEntity100001930 yago:Protein114728724 yago:Relation100031921 dbo:Drug yago:Substance100019613 yago:Thing100002452 yago:Unit109465459 umbel-rc:DrugProduct |
| rdfs:comment |
ماباتوموماب هو جسم مضاد وحيد النسيلة بشري تجريبي يخوض تجاربه السريرية لعلاج السرطان. (ar) Mapatumumab (HGS-ETR1) is an experimental human monoclonal antibody undergoing clinical trials for the treatment of cancer. It targets TRAIL-R1, also known as DR4, which is expressed on the surface of many tumor cell types. (en) |
| rdfs:label |
ماباتوموماب (ar) Mapatumumab (en) |
| owl:sameAs |
freebase:Mapatumumab yago-res:Mapatumumab wikidata:Mapatumumab dbpedia-ar:Mapatumumab dbpedia-fa:Mapatumumab https://global.dbpedia.org/id/4rRZb |
| prov:wasDerivedFrom |
wikipedia-en:Mapatumumab?oldid=1102283529&ns=0 |
| foaf:isPrimaryTopicOf |
wikipedia-en:Mapatumumab |
| is dbo:wikiPageWikiLink of |
dbr:Cambridge_Antibody_Technology dbr:Human_Genome_Sciences dbr:TRAIL dbr:List_of_therapeutic_monoclonal_antibodies dbr:List_of_drugs:_M–Md |
| is foaf:primaryTopic of |
wikipedia-en:Mapatumumab |